Dawn Halkuff's most recent trade in Xeris Biopharma Holdings Inc was a trade of 42,500 Common Stock done at an average price of $7.3 . Disclosure was reported to the exchange on Aug. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Sale of securities on an exchange or to another person at price $ 7.28 per share. | 12 Aug 2025 | 42,500 | 115,000 (0%) | 0% | 7.3 | 309,226 | Common Stock |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 50,000 | 157,500 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 107,500 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 42,500 | 57,500 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 0 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 19,650 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) |